Pfizer's COVID-19 booster shot is safe, 95.6 percent effective against virus in patients 16 years and older

Several countries have already approved Covid-19 booster shots to increase immunity in people who have already been vaccinated, but whose protection may have dipped after several months, per some studies.

|Oct 22, 2021, 17:37:46 IST

A booster shot of the anti-Covid-19 vaccine developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection, according to trial data published by the makers on Thursday.The clinical phase three trial with "10,000 participants 16 years of age and older" showed "a relative vaccine efficacy of 95.6 percent against disease during a period when Delta was the prevalent strain", the companies said in a statement.The study presented the "first results" of a booster trial, with a third shot of the vaccine demonstrating a "favourable safety profile"."These results provide further evidence of the benefits of boosters as we aim to keep people well-protected against this disease," said Pfizer CEO Albert Bourla.The preliminary results would be shared with regulatory agencies "as soon as possible", the companies said in the statement.Several countries have already approved Covid-19 booster shots to increase immunity in people who have already been vaccinated, but whose protection may have dipped after several months, per some studies.In the United States, the federal Food and Drug Administration (FDA) approved a third dose in September for everyone aged 65 and up, as well as people at high risk of developing severe Covid.The European Medicines Agency (EMA) approved a booster for over-18s at the beginning of October, allowing national regulators to decide which groups should be eligible first.In Israel, authorities have gone further, approving booster shots for everyone aged 12 and over.

Stroke in young adults, silent symptoms and late diagnosis: India's growing brain health challenge

Neurologists warn that stroke is increasingly affecting people in their 30s and 40s, while many brain disorders progress silently before symptoms appear. They say early diagnosis, timely referrals and healthier lifestyles are key to reducing India's growing neurological disease burden.

5 min read

Brain tumours aren't always fatal, but delayed diagnosis can be: Experts explain the key warning signs

Brain tumours are frequently mistaken for common headaches, stress or age-related cognitive changes. Doctors say recognising warning signs early and adopting a brain-healthy lifestyle can improve outcomes and reduce the risk of long-term neurological complications.

2 min read

Spices, health and the Indian plate: Why chilli can be good for you—but moderation is still key

From boosting metabolism to supporting heart health, chillies offer several surprising health benefits. But experts say the amount you eat matters, and too much spice can do more harm than good.

4 min read

Organ donation: 5 myths you need to stop believing, according to a transplant specialist

Organ donation has the power to transform and save lives, but this can happen only when myths are replaced with facts. Building awareness, having open conversations and understanding the process can help families make informed decisions.

2 min read

Fish over meat: Why a pescatarian diet may help people with obesity live longer

A large UK study tracking over 150,000 adults with clinical obesity found pescatarians outlived regular meat-eaters, while vegetarians and vegans saw no similar benefit, but experts say the findings don't translate simply to Indian diets.